Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
68.3M
-
Shares change
-
-5.66M
-
Total reported value, excl. options
-
$58.9M
-
Value change
-
-$24.6M
-
Put/Call ratio
-
0.03
-
Number of buys
-
46
-
Number of sells
-
-97
-
Price
-
$0.86
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q3 2023
195 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q3 2023.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.3M shares
of 101M outstanding shares and own 67.68% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (14.7M shares), VANGUARD GROUP INC (9.06M shares), BlackRock Inc. (8.04M shares), ARMISTICE CAPITAL, LLC (7.89M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (2.56M shares), MILLENNIUM MANAGEMENT LLC (2.27M shares), Assenagon Asset Management S.A. (2.23M shares), GEODE CAPITAL MANAGEMENT, LLC (1.88M shares), TWO SIGMA INVESTMENTS, LP (1.86M shares), and STATE STREET CORP (1.71M shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.